EN

Rankings / Health Care

Agilent Technologies A

Analytical instruments. Agilent Technologies, Inc., listed on NYSE.

Based on the FY2025 annual report (Nov 2024 – Oct 2025)

Agilent Technologies' market cap is
about $48.44 billion.

#223 by market cap among 289 companies, based on the Nov 5, 2026 close. FY2025 revenue was $6.948B.

Share price (close)
$171.78
Close on Nov 5, 2026 · per share
P/E ratio
37.6x
Closing price ÷ latest annual EPS
Market cap
$48.44B
#223 of 289
Revenue
$6.948B
#248 of 299 · +6.7% YoY
Operating income
$1.479B
#183 of 231 · −0.6% YoY
Net income
$1.303B
#230 of 298 · +1.1% YoY
Free cash flow
$1.152B
#211 of 261 · −16.1% YoY
Total assets
$12.727B
#257 of 299 · +7.4% YoY
Dividends paid
$282M
#195 of 214 · +2.9% YoY
Dividend per share
$0.99
#174 of 205 · +5.1% YoY
Dividend yield
0.6%
#175 of 203
Shares outstanding
283,054,377 shares
As of Oct 31, 2025

Where the revenue went

Revenue is set at 100% and split into what went to costs, R&D, operating expenses and taxes, and what was left as profit.

  • Cost of revenue47.6%
  • R&D6.5%
  • SG&A and other24.6%
  • Taxes, interest & other2.5%
  • Net income18.8%

Profitability and stability

Each figure comes with its rank among 300 companies. The further right the dot, the higher the rank.

Revenue growthHow much revenue grew from the previous fiscal year
+6.7%
#175 of 299
Revenue is growing steadily. The median across 299 companies is +7.9%.
Operating marginShare of revenue kept as profit from the core business
21.3%
#98 of 231
21.3% of revenue was kept as operating profit. The median across 231 companies is 19.2%.
Net marginShare of revenue left as profit after interest and taxes
18.8%
#103 of 298
After taxes, 18.8% of revenue was left as net income. The median across 298 companies is 14.0%.
FCF marginShare of revenue left as cash after capital spending
16.6%
#127 of 261
Cash is left over after capital spending. The median across 261 companies is 15.8%.
ROEHow much profit the company earned on shareholders' equity in a year
20.6%
#120 of 276
Earns a lot relative to its equity. The median across 276 companies is 16.8%.
Debt-to-equityLiabilities relative to equity. Lower means less debt
88.8%
#62 of 244
Liabilities are smaller than equity. The median across 244 companies is 159.6%.

Revenue and profit over time

Gray bars show revenue and the green part inside shows net income. The number above each bar is revenue (abbreviated) and the number below is net margin. Hover over a bar to see the exact amounts.

FY2021 Revenue $6.319B / Net income $1.21B6.32B19.1%FY2021FY2022 Revenue $6.848B / Net income $1.254B6.85B18.3%FY2022FY2023 Revenue $6.833B / Net income $1.24B6.83B18.1%FY2023FY2024 Revenue $6.51B / Net income $1.289B6.51B19.8%FY2024FY2025 Revenue $6.948B / Net income $1.303B6.95B18.8%FY2025
Currency: US dollars. Years are the years in which each fiscal year ended.

Where the cash went

Unlike profit, cash flow is money that actually came in and went out.

  • Cash from operations$1.559B
  • Capital spending−$407M
  • Free cash flow (FCF)$1.152B
  • Dividends paid−$282M

Whose money funds the assets

The company's assets, split into borrowed money (liabilities) and shareholders' money (equity).

  • Total assets$12.727B
  • Total liabilities$5.986B
  • Total equity$6.741B
  • Cash and equivalents$1.789B

Compared with similar companies

Based on each company's latest annual report, so fiscal year ends may differ.

Compare in detail
CompanyAnnual revenueNet incomeRevenue growthOperating marginNet margin
Agilent TechnologiesA$6.948B$1.303B+6.7%21.3%18.8%
WatersWAT$3.165286B$642.629M+7.0%25.4%20.3%
IQVIAIQV$16.31B$1.36B+5.9%13.4%8.3%
Mettler-ToledoMTD$4.026399B$869.193M+4.0%—21.6%
DanaherDHR$24.568B$3.614B+2.9%19.1%14.7%

What the company does

Agilent makes analytical instruments such as chromatographs and mass spectrometers used by drug, chemical and food companies.

The fiscal year ends around October each year.

Related companies: Waters, IQVIA, Mettler-Toledo, Danaher

Financial statements

Last 5 fiscal years. Currency: US dollars.

Show the table
ItemFY2021FY2022FY2023FY2024FY2025
Revenue6.319B6.848B6.833B6.51B6.948B
Cost of revenue2.912B3.126B3.368B2.975B3.305B
Gross profit3.407B3.722B3.465B3.535B3.643B
R&D expense441M467M481M479M455M
Operating income1.347B1.618B1.35B1.488B1.479B
Pretax income1.36B1.504B1.339B1.521B1.435B
Net income1.21B1.254B1.24B1.289B1.303B
EPS (diluted)$3.94$4.18$4.19$4.43$4.57
Operating cash flow1.485B1.312B1.772B1.751B1.559B
Capital expenditures188M291M298M378M407M
Free cash flow (FCF)1.297B1.021B1.474B1.373B1.152B
Dividends paid236M250M265M274M282M
Total assets10.705B10.532B10.763B11.846B12.727B
Total liabilities5.316B5.227B4.918B5.948B5.986B
Total equity5.389B5.305B−327M5.898B6.741B
Cash and equivalents1.484B1.053B1.59B1.329B1.789B
Original filing10-K10-K10-K10-K10-K

Source: SEC EDGAR filings for Agilent Technologies, Inc. · CIK 0001090872 · US-GAAP